Head to head
Lumentum vs Cisco
Side-by-side on the measures that matter, with a plain-English read. Full detail: LITE · CSCO
LITE
Lumentum
460.54-13.94%
1-year price shape — +97% over the period
Quant Rating D · 98/100
vs
CSCO
Cisco
90.64-4.29%
1-year price shape — +22% over the period
Quant Rating D · 67/100
1-year performance, rebased to 100
Cisco edges it on the scoreable measures. Cisco pays the highest dividend yield; Cisco earns the most per share.
| LITE | CSCO | |
|---|---|---|
| Snapshot | ||
| Sector | Communication Equipment | Communication Equipment |
| Last price | 460.54 | 90.64 |
| Change today | -13.94% | -4.29% |
| 1-year return | +97.5% | +21.9% |
| Market cap | $41.77B | $357.34B |
| 52-week range | 266.01 – 1,143.00 | 71.86 – 129.38 |
| Valuation | ||
| P/E (TTM) | -5.15 | 24.17 |
| P/E percentile, own 5-yr range | 49th | 64th |
| P/B | 9.13 | 6.92 |
| Dividend yield | 0.00% | 1.84% |
| Profitability & growth | ||
| EPS (TTM) | -92.96 | 3.33 |
| Net profit (TTM) | $-8.43B | $13.13B |
| Revenue (TTM) | $3.74B | $66.96B |
| Provider revenue period date | 2026-09-25 | 2026-10-23 |
| Revenue growth (YoY) | +136.5% | +24.4% |
| Gross margin | 45.9% | 64.1% |
| Operating margin | 23.4% | 27.1% |
| Net margin | -175.8% | 22.3% |
| Free cash flow (TTM) | $356.30M | $13.73B |
| Provider cash-flow period date | 2026-09-25 | 2026-10-23 |
| Ownership & sentiment | ||
| Institutional ownership | 94.2% | 81.0% |
| Insider activity (12mo) | 3 buy / 47 sell | 19 buy / 30 sell |
| Short interest (% of float) | 9.0% | 1.5% |
| Analyst consensus | 79% buy / 21% hold (19) | 71% buy / 29% hold (17) |
| Analyst price target | $1,099 (+139%) | $130 (+43%) |
| StockVane view | ||
| StockVane Quant Rating | D (98) | D (67) |
| Company | ||
| Employees | 13,757 | 82,400 |
| Founded | 1979 | 1984 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.